Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nanoparticle-Based Therapeutics for Brain Injury.

Vimala N Bharadwaj1, Duong T Nguyen1, Vikram D Kodibagkar1

  • 1School of Biological and Health Systems Engineering, Arizona State University, P.O. Box 879709, Tempe, AZ, 85287, USA.

Advanced Healthcare Materials
|October 17, 2017
PubMed
Summary

Nanoparticles (NPs) offer promising strategies for brain injury treatment by targeting the leaky blood-brain barrier (BBB). This review explores NP applications for neuroprotection in stroke and trauma, aiming to improve diagnostics and therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Solvent-free Nanoparticle Assembly Protocol (SNAP): one-pot formulation of drug loaded polyester nanoparticles and their vessel size-dependent perivascular transport in the brain.

bioRxiv : the preprint server for biology·2026
Same author

A guest-host hydrogel for neural tissue engineering applications.

Journal of materials chemistry. B·2026
Same author

Biomimetic MRI Nanoprobe for Mapping Cerebrovascular Inflammation After Traumatic Brain Injury.

bioRxiv : the preprint server for biology·2026
Same author

Comparison of HDO production from [2,3,4,6,6- <sup>2</sup> H <sub>5</sub> ]Glucose and [ <sup>2</sup> H <sub>7</sub> ]Glucose as a marker of Glucose metabolism.

bioRxiv : the preprint server for biology·2026
Same author

Differential sex-dependent responses of circulating steroid hormones and cortical gene expression in a preclinical traumatic brain injury model.

bioRxiv : the preprint server for biology·2026
Same author

Virulence and genomic analysis of <i>Puccinia coronata</i> f. sp. <i>avenae</i> in Australia identifies new races and a new lineage in 2024.

Plant disease·2026

Area of Science:

  • Neuroscience
  • Biomedical Engineering
  • Pharmacology

Background:

  • Brain injuries, including stroke and trauma, cause significant patient suffering and societal costs.
  • Current treatments are limited by the complex pathology of the blood-brain barrier (BBB).
  • The BBB exhibits transient and extended reopening periods following brain injury, presenting therapeutic opportunities.

Purpose of the Study:

  • To survey nanoparticle (NP) strategies for treating cerebral ischemia and brain trauma.
  • To explore the potential of NPs for neuroprotection and neurovascular unit preservation.
  • To provide insights for enhancing NP-based diagnostic and therapeutic approaches for brain injuries.

Main Methods:

  • Literature review of NP strategies in cerebral ischemia and brain trauma.
Keywords:
blood-brain barriercerebral ischemiananoparticlestherapeutic nanoparticle deliverytraumatic brain injury

Related Experiment Videos

  • Analysis of BBB dynamics and receptor expression in brain injury.
  • Evaluation of NP delivery mechanisms for therapeutic interventions.

    • Main Results:

    • Nanoparticles (NPs) can exploit the leaky blood-brain barrier (BBB) for targeted drug delivery.
    • NP strategies aim to protect the pericontusional/penumbra area in brain injuries.
    • Alterations in BBB permeability and receptor expression are key targets for NP interventions.

    Conclusions:

    • Nanoparticle-based approaches hold significant potential for improving brain injury diagnostics and therapeutics.
    • Targeting the dynamic BBB with NPs can enhance neuroprotection and preserve the neurovascular unit.
    • Further research into NP design and delivery is crucial for optimizing treatment outcomes.